zoledronic acid has been researched along with Leukemia, Promyelocytic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YX; Li, XB; Liang, JY; Liu, LL; Liu, SS; Lu, Y; Wang, XP; Zhong, XY | 1 |
| Carcas, AJ; Cordoba, R; Hernandez-Navarro, F; Lei, SH; Lopez de la Guia, A; Ramirez, E; Sanjurjo, MJ | 1 |
2 other study(ies) available for zoledronic acid and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Zoledronic acid exerts antitumor effects in NB4 acute promyelocytic leukemia cells by inducing apoptosis and S phase arrest.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Diphosphonates; Dose-Response Relationship, Drug; Humans; Imidazoles; Leukemia, Promyelocytic, Acute; S Phase; Treatment Outcome; Zoledronic Acid | 2014 |
Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid.
Topics: Adult; Antineoplastic Agents; Diphosphonates; Drug Interactions; Drug Therapy, Combination; Humans; Hypercalcemia; Imidazoles; Itraconazole; Leukemia, Promyelocytic, Acute; Male; Treatment Outcome; Tretinoin; Zoledronic Acid | 2008 |